Skip to main content
Erschienen in: Journal of General Internal Medicine 2/2007

01.02.2007 | Original Article

Physicians and Drug Representatives: Exploring the Dynamics of the Relationship

verfasst von: Susan Chimonas, Troyen A. Brennan, David J. Rothman

Erschienen in: Journal of General Internal Medicine | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

Interactions between physicians and drug representatives are common, even though research shows that physicians understand the conflict of interest between marketing and patient care. Little is known about how physicians resolve this contradiction.

Objective

To determine physicians’ techniques for managing cognitive inconsistencies within their relationships with drug representatives.

Design, Setting, and Participants

Six focus groups were conducted with 32 academic and community physicians in San Diego, Atlanta, and Chicago.

Measurements

Qualitative analysis of focus group transcripts to determine physicians’ attitudes towards conflict of interest and detailing, their beliefs about the quality of information conveyed and the impact on prescribing, and their resolution of the conflict between detailers’ desire to sell product and patient care.

Results

Physicians understood the concept of conflict of interest and applied it to relationships with detailers. However, they maintained favorable views of physician–detailer exchanges. Holding these mutually contradictory attitudes, physicians were in a position of cognitive dissonance. To resolve the dissonance, they used a variety of denials and rationalizations: They avoided thinking about the conflict of interest, they disagreed that industry relationships affected physician behavior, they denied responsibility for the problem, they enumerated techniques for remaining impartial, and they reasoned that meetings with detailers were educational and benefited patients.

Conclusions

Although physicians understood the concept of conflict of interest, relationships with detailers set up psychological dynamics that influenced their reasoning. Our findings suggest that voluntary guidelines, like those proposed by most major medical societies, are inadequate. It may be that only the prohibition of physician–detailer interactions will be effective.
Literatur
1.
Zurück zum Zitat Rodwin MA. Medicine, Money, and Morals: Physicians’ Conflict of Interest. Oxford: Oxford University Press; 1993. Rodwin MA. Medicine, Money, and Morals: Physicians’ Conflict of Interest. Oxford: Oxford University Press; 1993.
2.
Zurück zum Zitat Murray T. Conflict of interest in the professions. N Engl J Med. 2002; 346:1835–6.CrossRef Murray T. Conflict of interest in the professions. N Engl J Med. 2002; 346:1835–6.CrossRef
3.
Zurück zum Zitat Dana J, Lowenstein G. A social science perspective on gifts to physicians from industry. JAMA. 2003;290(2):252–5.PubMedCrossRef Dana J, Lowenstein G. A social science perspective on gifts to physicians from industry. JAMA. 2003;290(2):252–5.PubMedCrossRef
5.
Zurück zum Zitat Wazana A. Physicians and the pharmaceutical industry: Is a gift ever just a gift? JAMA. 2000;283:373–80.PubMedCrossRef Wazana A. Physicians and the pharmaceutical industry: Is a gift ever just a gift? JAMA. 2000;283:373–80.PubMedCrossRef
6.
Zurück zum Zitat Lexchin J. Interactions between physicians and the pharmaceutical industry: What does the literature say? Can Med Assoc J. 1993; 149:1401–7. Lexchin J. Interactions between physicians and the pharmaceutical industry: What does the literature say? Can Med Assoc J. 1993; 149:1401–7.
7.
Zurück zum Zitat Pear R. Drug industry is told to stop gifts to doctors. The New York Times. October 1, 2002;A1. Pear R. Drug industry is told to stop gifts to doctors. The New York Times. October 1, 2002;A1.
8.
Zurück zum Zitat Chimonas S, Rothman DJ. New federal guidelines for physician–pharmaceutical industry relations: the politics of policy formation. Health Aff. 2005;24,4:949–60.CrossRef Chimonas S, Rothman DJ. New federal guidelines for physician–pharmaceutical industry relations: the politics of policy formation. Health Aff. 2005;24,4:949–60.CrossRef
9.
Zurück zum Zitat Studdert DM, Mello MM, Brennan TA. Financial conflicts of interest in physician relationships with the pharmaceutical industry: Self-regulation in the shadow of federal prosecution. N Engl J Med. 2004; 351:1891–1900.PubMedCrossRef Studdert DM, Mello MM, Brennan TA. Financial conflicts of interest in physician relationships with the pharmaceutical industry: Self-regulation in the shadow of federal prosecution. N Engl J Med. 2004; 351:1891–1900.PubMedCrossRef
11.
Zurück zum Zitat Medical Professionalism Project. Medical professionalism in the new millennium: a physician charter. Ann Intern Med. 2002;136:243–46. Medical Professionalism Project. Medical professionalism in the new millennium: a physician charter. Ann Intern Med. 2002;136:243–46.
12.
Zurück zum Zitat Brett AS, Burr W, Moloo J. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians. Arch Intern Med. 2003; 163:2213–18.PubMedCrossRef Brett AS, Burr W, Moloo J. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians. Arch Intern Med. 2003; 163:2213–18.PubMedCrossRef
13.
Zurück zum Zitat Reeder M, Dougherty J, White L. Pharmaceutical representatives and emergency medicine residents: a national survey. Ann Emerg Med. 1993; 22:1593–6.PubMedCrossRef Reeder M, Dougherty J, White L. Pharmaceutical representatives and emergency medicine residents: a national survey. Ann Emerg Med. 1993; 22:1593–6.PubMedCrossRef
14.
Zurück zum Zitat Hodges B. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns, and clerks. Can Med Assoc J. 1995;153:553–9. Hodges B. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns, and clerks. Can Med Assoc J. 1995;153:553–9.
15.
Zurück zum Zitat Sergeant M, Hodgetts P, Godwin M, Walker D, McHenry P. Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario. Can Med Assoc J. 1996;155:1243–8. Sergeant M, Hodgetts P, Godwin M, Walker D, McHenry P. Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario. Can Med Assoc J. 1996;155:1243–8.
16.
Zurück zum Zitat McKinney WP, Schiedermayer DL, Lurie N, Simpson DE, Goodman JL, Rich, EC. Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. JAMA. 1990;264:1693–7.PubMedCrossRef McKinney WP, Schiedermayer DL, Lurie N, Simpson DE, Goodman JL, Rich, EC. Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. JAMA. 1990;264:1693–7.PubMedCrossRef
17.
Zurück zum Zitat Banks J, Mainous A. Attitudes of medical school faculty toward gifts from the pharmaceutical industry. Acad Med. 1992;67:610–12.PubMedCrossRef Banks J, Mainous A. Attitudes of medical school faculty toward gifts from the pharmaceutical industry. Acad Med. 1992;67:610–12.PubMedCrossRef
18.
Zurück zum Zitat Keim S, Sanders A, Witzke D, Dyne P, Fulginiti J. Beliefs and practices of emergency medicine faculty and residents regarding professional interactions with the biomedical industry. Ann Emerg Med. 1993;22:1576–81.PubMedCrossRef Keim S, Sanders A, Witzke D, Dyne P, Fulginiti J. Beliefs and practices of emergency medicine faculty and residents regarding professional interactions with the biomedical industry. Ann Emerg Med. 1993;22:1576–81.PubMedCrossRef
19.
Zurück zum Zitat Steinman M, Shlipak M, McPhee S. Of principles and pens: attitudes and practices of medicine house staff toward pharmaceutical industry promotions. Am J Med. 2001;110:551–7.PubMedCrossRef Steinman M, Shlipak M, McPhee S. Of principles and pens: attitudes and practices of medicine house staff toward pharmaceutical industry promotions. Am J Med. 2001;110:551–7.PubMedCrossRef
20.
Zurück zum Zitat Madhavan S, Amonkar M, Elliott D, Burke K, Gore P. The gift relationship between pharmaceutical companies and physicians: an exploratory survey of physicians. J Clin Pharm Ther. 1997;22:207–15.PubMedCrossRef Madhavan S, Amonkar M, Elliott D, Burke K, Gore P. The gift relationship between pharmaceutical companies and physicians: an exploratory survey of physicians. J Clin Pharm Ther. 1997;22:207–15.PubMedCrossRef
21.
Zurück zum Zitat Festinger L, Riecken H, Schachter S. When Prophecy Fails. Minneapolis, MN: Lund Press; 1956. Festinger L, Riecken H, Schachter S. When Prophecy Fails. Minneapolis, MN: Lund Press; 1956.
22.
Zurück zum Zitat Festinger L. A Theory of Cognitive Dissonance. Stanford, CA: Stanford University Press; 1957. Festinger L. A Theory of Cognitive Dissonance. Stanford, CA: Stanford University Press; 1957.
23.
Zurück zum Zitat Morgan D. Focus Groups as Qualitative Research. 2nd edition. Thousand Oaks, CA: Sage Publications; 1997. Morgan D. Focus Groups as Qualitative Research. 2nd edition. Thousand Oaks, CA: Sage Publications; 1997.
24.
Zurück zum Zitat American Medical Association. “Gifts to physicians from industry.” JAMA 1991;265:501. American Medical Association. “Gifts to physicians from industry.” JAMA 1991;265:501.
26.
Zurück zum Zitat Office of the Inspector General. Compliance program guidance for pharmaceutical manufacturers. Fed Regist. 2003;68,86:23731–43. Office of the Inspector General. Compliance program guidance for pharmaceutical manufacturers. Fed Regist. 2003;68,86:23731–43.
27.
Zurück zum Zitat Carroll R. “Cognitive dissonance.” The Skeptic’s Dictionary: A Collection of Strange Beliefs, Amusing Deceptions, and Dangerous Delusions. Hoboken, NJ: John Wiley & Sons; 2003. Carroll R. “Cognitive dissonance.” The Skeptic’s Dictionary: A Collection of Strange Beliefs, Amusing Deceptions, and Dangerous Delusions. Hoboken, NJ: John Wiley & Sons; 2003.
28.
Zurück zum Zitat Coyle S. Physician–industry relations. Part 1: individual physicians. Ann Intern Med. 2002;136:396–402.PubMed Coyle S. Physician–industry relations. Part 1: individual physicians. Ann Intern Med. 2002;136:396–402.PubMed
29.
Zurück zum Zitat Brennan TA, Rothman DJ, Blank L, et al. Health industry practices that create conflicts of interest: A policy proposal for academic medical centers. JAMA. 2006;295,4:429–33.PubMedCrossRef Brennan TA, Rothman DJ, Blank L, et al. Health industry practices that create conflicts of interest: A policy proposal for academic medical centers. JAMA. 2006;295,4:429–33.PubMedCrossRef
30.
Zurück zum Zitat Hensley S. “As Drug Bill Soars, Some Doctors Get an ‘Unsales’ Pitch.” The Wall Street Journal. March 13, 2006;A1. Hensley S. “As Drug Bill Soars, Some Doctors Get an ‘Unsales’ Pitch.” The Wall Street Journal. March 13, 2006;A1.
31.
Zurück zum Zitat Schneider JA, Arora V, Kasza K, Van Harrison R, Humphrey H. Residents’ perceptions over time of pharmaceutical industry: interactions and gifts and the effect of an educational intervention. Acad Med. 2006;81(7):595–602.PubMedCrossRef Schneider JA, Arora V, Kasza K, Van Harrison R, Humphrey H. Residents’ perceptions over time of pharmaceutical industry: interactions and gifts and the effect of an educational intervention. Acad Med. 2006;81(7):595–602.PubMedCrossRef
32.
Zurück zum Zitat Appleby J. “Sales pitch: Drug firms use perks to push pills.” USA Today. May 16, 2001;B1. Appleby J. “Sales pitch: Drug firms use perks to push pills.” USA Today. May 16, 2001;B1.
34.
Zurück zum Zitat Allen D. “Drug companies woo Vermont doctors.” The Barre Montpelier Times (Argus and Rutland Herald). May 29, 2005: A1, A6. Allen D. “Drug companies woo Vermont doctors.” The Barre Montpelier Times (Argus and Rutland Herald). May 29, 2005: A1, A6.
Metadaten
Titel
Physicians and Drug Representatives: Exploring the Dynamics of the Relationship
verfasst von
Susan Chimonas
Troyen A. Brennan
David J. Rothman
Publikationsdatum
01.02.2007
Verlag
Springer-Verlag
Erschienen in
Journal of General Internal Medicine / Ausgabe 2/2007
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-006-0041-z

Weitere Artikel der Ausgabe 2/2007

Journal of General Internal Medicine 2/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.